Electrophysiology and adult congenital heart disease: Advances and options

Progress in Cardiovascular Diseases

Volumn 53, Issue 4, 2011, Pages 281-292

  Abadir, Sylvia ^a   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DABIGATRAN; DOFETILIDE; DRONEDARONE; LEAD; PLACEBO; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADULT; ADULT CONGENITAL HEART DISEASE; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; COMPUTER ASSISTED RADIOGRAPHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART SEPTUM DEFECT; HEART SINGLE VENTRICLE; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; LUNG TOXICITY; METAL EXTRACTION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; ROBOTICS; SINUS NODE; SINUS RHYTHM; SKIN TOXICITY; TACHYCARDIA; THYROID DISEASE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BENZIMIDAZOLES; BETA-ALANINE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART DEFECTS, CONGENITAL; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; PHENETHYLAMINES; SULFONAMIDES; SURVIVORS; TETRALOGY OF FALLOT;

EID: 79551481540     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2010.07.003     Document Type: Article

References (114)

1. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
2. Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart 2002, 88(Suppl 1):i1-i14.
3. Gatzoulis M.A., Hechter S., Siu S.C., et al. Outpatient clinics for adults with congenital heart disease: increasing workload and evolving patterns of referral. Heart 1999, 81:57-61.
4. Walsh E.P., Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007, 115:534-545.
5. Collins K.K., Love B.A., Walsh E.P., et al. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol 2000, 86:969-974.
6. Deal B.J., Mavroudis C., Backer C.L., et al. Impact of arrhythmia circuit cryoablation during Fontan conversion for refractory atrial tachycardia. Am J Cardiol 1999, 83:563-568.
7. Marcelletti C.F., Hanley F.L., Mavroudis C., et al. Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience. J Thorac Cardiovasc Surg 2000, 119:340-346.
8. Gatzoulis M.A., Freeman M.A., Siu S.C., et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999, 340:839-846.
9. Wells R., Khairy P., Harris L., et al. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol 2009, 32:1313-1318.
10. Hoyer A.W., Balaji S. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol 2007, 30:1003-1008.
11. Thorne S.A., Barnes I., Cullinan P., et al. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 1999, 100:149-154.
12. Gwilt M., Arrowsmith J.E., Blackburn K.J., et al. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J Pharmacol Exp Ther 1991, 256:318-324.
13. Ferguson J.J. Meeting highlights. Highlights of the 71st scientific sessions of the American Heart Association. Circulation 1999, 99:2486-2491.
14. Kober L., Bloch Thomsen P.E., Moller M., et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000, 356:2052-2058.
15. Pedersen O.D., Bagger H., Keller N., et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 2001, 104:292-296.
16. Singh S., Zoble R.G., Yellen L., et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000, 102:2385-2390.
17. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999, 341:857-865.
18. Sun W., Sarma J.S., Singh B.N. Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone. Circulation 1999, 100:2276-2281.
19. Hohnloser S.H., Crijns H.J., van Eickels M., et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009, 360:668-678.
20. Singh B.N., Connolly S.J., Crijns H.J., et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007, 357:987-999.
21. Sanofi-aventis DIONYSOS Study results showed the respective profiles of dronedarone and amiodarone 2008, Available at:. http://ensanofi-aventiscom/binaries/20081223_dionysos_fe_en_en_tcm28-23624pdf.
22. Piccini J.P., Hasselblad V., Peterson E.D., et al. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009, 54:1089-1095.
23. Kober L., Torp-Pedersen C., McMurray J.J., et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008, 358:2678-2687.
24. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1-e121.
25. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
26. Nielsen J.C., Pedersen A.K., Mortensen P.T., et al. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace 1999, 1:113-120.
27. Mansour F., Talajic M., Thibault B., et al. Pacemaker troubleshooting: when MVP is not the most valuable parameter. Heart Rhythm 2006, 3:612-614.
28. Marcotte F., Poirier N., Pressacco J., et al. Evaluation of adult congenital heart disease by cardiac magnetic resonance imaging. Congenit Heart Dis 2009, 4:216-230.
29. Dyrda K., Khairy P. Implantable rhythm devices and electromagnetic interference: myth or reality?. Expert Rev Cardiovasc Ther 2008, 6:823-832.
30. Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm 2008, 5:1464-1472.
31. Rhodes L.A., Walsh E.P., Gamble W.J., et al. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol 1995, 18:1005-1016.
32. Stephenson E.A., Casavant D., Tuzi J., et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003, 92:871-876.
33. Fortescue E.B., Berul C.I., Cecchin F., et al. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 2004, 1:150-159.
34. Walker F., Siu S.C., Woods S., et al. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 2004, 43:1894-1901.
35. Cohen M.I., Bush D.M., Vetter V.L., et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation 2001, 103:2585-2590.
36. Chintala K., Forbes T.J., Karpawich P.P. Effectiveness of transvenous pacemaker leads placed through intravascular stents in patients with congenital heart disease. Am J Cardiol 2005, 95:424-427.
37. Tzifa A., Marshall A.C., McElhinney D.B., et al. Endovascular treatment for superior vena cava occlusion or obstruction in a pediatric and young adult population: a 22-year experience. J Am Coll Cardiol 2007, 49:1003-1009.
38. Khairy P., Roux J.F., Dubuc M., et al. Laser lead extraction in adult congenital heart disease. J Cardiovasc Electrophysiol 2007, 18:507-511.
39. Friedman R.A., Van Zandt H., Collins E., et al. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol 1996, 19:778-783.
40. Hosein R.B., Clarke A.J., McGuirk S.P., et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'?. Eur J Cardiothorac Surg 2007, 31:344-352. discussion 53.
41. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation 2006, 113:2391-2397.
42. Silva J.N., Ghosh S., Bowman T.M., et al. Cardiac resynchronization therapy in pediatric congenital heart disease: insights from noninvasive electrocardiographic imaging. Heart Rhythm 2009, 6:1178-1185.
43. Sogaard P., Kim W.Y., Jensen H.K., et al. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue doppler and three-dimensional echocardiographic study. Cardiology 2001, 95:173-182.
44. Vitarelli A., Franciosa P., Conde Y., et al. Echocardiographic assessment of ventricular asynchrony in dilated cardiomyopathy and congenital heart disease: tools and hopes. J Am Soc Echocardiogr 2005, 18:1424-1439.
45. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008, 117:2608-2616.
46. Raedle-Hurst T.M., Mueller M., Rentzsch A., et al. Assessment of left ventricular dyssynchrony and function using real-time 3-dimensional echocardiography in patients with congenital right heart disease. Am Heart J 2009, 157:791-798.
47. Harel F., Finnerty V., Gregoire J., et al. Comparison of left ventricular contraction homogeneity index using SPECT gated blood pool imaging and planar phase analysis. J Nucl Cardiol 2008, 15:80-85.
48. Strickberger S.A., Conti J., Daoud E.G., et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 2005, 111:2146-2150.
49. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:1115-1140.
50. Dubin A.M., Feinstein J.A., Reddy V.M., et al. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation 2003, 107:2287-2289.
51. Janousek J., Vojtovic P., Hucin B., et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 2001, 88:145-152.
52. Zimmerman F.J., Starr J.P., Koenig P.R., et al. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003, 75:1775-1780.
53. Dubin A.M., Janousek J., Rhee E., et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005, 46:2277-2283.
54. Bacha E.A., Zimmerman F.J., Mor-Avi V., et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg 2004, 78:1678-1683.
55. Janousek J., Gebauer R.A. Cardiac resynchronization therapy in pediatric and congenital heart disease. Pacing Clin Electrophysiol 2008, 31(Suppl 1):S21-S23.
56. Khairy P., Fournier A., Thibault B., et al. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol 2006, 109:160-168.
57. Strieper M., Karpawich P., Frias P., et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol 2004, 94:1352-1354.
58. Janousek J., Gebauer R.A., Abdul-Khaliq H., et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart 2009, 95:1165-1171.
59. Uemura H., Ho S.Y., Anderson R.H., et al. Surgical anatomy of the coronary circulation in hearts with discordant atrioventricular connections. Eur J Cardiothorac Surg 1996, 10:194-200.
60. Juneja R., Rowland E., Ho S.Y. Atrial morphology in hearts with congenitally corrected transposition of the great arteries: implications for the interventionist. J Cardiovasc Electrophysiol 2002, 13:158-163.
61. Levine J.C., Walsh E.P., Saul J.P. Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome. Am J Cardiol 1993, 72:689-693.
62. Oechslin E.N., Harrison D.A., Connelly M.S., et al. Mode of death in adults with congenital heart disease. Am J Cardiol 2000, 86:1111-1116.
63. Epstein A.E., Dimarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm 2008, 5:934-955.
64. Gillette P.C., Garson A. Sudden cardiac death in the pediatric population. Circulation 1992, 85:I64-I69.
65. Nollert G., Fischlein T., Bouterwek S., et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997, 30:1374-1383.
66. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
67. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation 2004, 109:1994-2000.
68. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med 2007, 4:292-293.
69. Khairy P., Harris L., Landzberg M.J., et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008, 117:363-370.
70. Khairy P., Dore A., Poirier N., et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther 2009, 7:755-762.
71. Gatzoulis M.A., Walters J., McLaughlin P.R., et al. Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction?. Heart 2000, 84:409-415.
72. Gelatt M., Hamilton R.M., McCrindle B.W., et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997, 29:194-201.
73. Silka M.J., Hardy B.G., Menashe V.D., et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998, 32:245-251.
74. Janousek J., Paul T., Luhmer I., et al. Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death. ZKardiol 1994, 83:933-938.
75. Kammeraad J.A., van Deurzen C.H., Sreeram N., et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004, 44:1095-1102.
76. Schwerzmann M., Salehian O., Harris L., et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J 2009, 30:1873-1879.
77. Khairy P., Harris L., Landzberg M.J., et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 2008, 1:250-257.
78. Khairy P., Fernandes S.M., Mayer J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008, 117:85-92.
79. Berul C.I., Van Hare G.F., Kertesz N.J., et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008, 51:1685-1691.
80. Yap S.C., Roos-Hesselink J.W., Hoendermis E.S., et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J 2007, 28:1854-1861.
81. Stephenson E.A., Batra A.S., Knilans T.K., et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006, 17:41-46.
82. Jolley M., Stinstra J., Pieper S., et al. A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm 2008, 5:565-572.
83. Triedman J.K., Alexander M.E., Love B.A., et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 2002, 39:1827-1835.
84. Greene A.E., Skinner J.R., Dubin A.M., et al. The electrophysiology of atrioventricular nodal reentry tachycardia following the Mustard or Senning procedure and its radiofrequency ablation. Cardiol Young 2005, 15:611-616.
85. Walsh E.P. Interventional electrophysiology in patients with congenital heart disease. Circulation 2007, 115:3224-3234.
86. Kannankeril P.J., Anderson M.E., Rottman J.N., et al. Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease. Am J Cardiol 2003, 92:879-881.
87. Khairy P., Van Hare G.F. Catheter ablation in transposition of the great arteries with Mustard or Senning baffles. Heart Rhythm 2009, 6:283-289.
88. Triedman J.K., DeLucca J.M., Alexander M.E., et al. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm 2005, 2:700-705.
89. Khairy P., Poirier N., Mercier L.A. Univentricular heart. Circulation 2007, 115:800-812.
90. Nehgme R.A., Carboni M.P., Care J., et al. Transthoracic percutaneous access for electroanatomic mapping and catheter ablation of atrial tachycardia in patients with a lateral tunnel Fontan. Heart Rhythm 2006, 3:37-43.
91. Khairy P., Fournier A., Ruest P., et al. Transcatheter ablation via a sternotomy approach as a hybrid procedure in a univentricular heart. Pacing Clin Electrophysiol 2008, 31:639-640.
92. Dave A.S., Aboulhosn J., Child J.S., et al. Transconduit puncture for catheter ablation of atrial tachycardia in a patient with extracardiac Fontan palliation. Heart Rhythm 2010, 7:413-416.
93. Earley M.J., Showkathali R., Alzetani M., et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 2006, 27:1223-1229.
94. Khairy P., Stevenson W.G. Catheter ablation in tetralogy of Fallot. Heart Rhythm 2009, 6:1069-1074.
95. Kriebel T., Saul J.P., Schneider H., et al. Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot. J Am Coll Cardiol 2007, 50:2162-2168.
96. Zeppenfeld K., Schalij M.J., Bartelings M.M., et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007, 116:2241-2252.
97. Khairy P., Chauvet P., Lehmann J., et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003, 107:2045-2050.
98. Lemola K., Dubuc M., Khairy P. Transcatheter cryoablation part II: clinical utility. Pacing Clin Electrophysiol 2008, 31:235-244.
99. Khairy P., Rivard L., Guerra P.G., et al. Morphometric ablation lesion characteristics comparing 4, 6, and 8 mm electrode-tip cryocatheters. J Cardiovasc Electrophysiol 2008, 19:1203-1207.
100. Khairy P., Mercier L.A., Dore A., et al. Partial atrioventricular canal defect with inverted atrioventricular nodal input into an inferiorly displaced atrioventricular node. Heart Rhythm 2007, 4:355-358.
101. Khairy P., Cartier C., Chauvet P., et al. A novel hybrid transcatheter ablation system that combines radiofrequency and cryoenergy. J Cardiovasc Electrophysiol 2008, 19:188-193.
102. Bar-Cohen Y., Cecchin F., Alexander M.E., et al. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm 2006, 3:253-258.
103. Kriebel T., Broistedt C., Kroll M., et al. Efficacy and safety of cryoenergy in the ablation of atrioventricular reentrant tachycardia substrates in children and adolescents. J Cardiovasc Electrophysiol 2005, 16:960-966.
104. Peichl P., Kautzner J., Gebauer R. Ablation of atrial tachycardias after correction of complex congenital heart diseases: utility of intracardiac echocardiography. Europace 2009, 11:48-53.
105. Ernst S. Robotic approach to catheter ablation. Curr Opin Cardiol 2008, 23:28-31.
106. Steven D., Servatius H., Rostock T., et al. Reduced fluoroscopy during atrial fibrillation ablation: benefits of robotic guided navigation. J Cardiovasc Electrophysiol 2010, 21:6-12.
107. Wood M.A., Orlov M., Ramaswamy K., et al. Remote magnetic versus manual catheter navigation for ablation of supraventricular tachycardias: a randomized, multicenter trial. Pacing Clin Electrophysiol 2008, 31:1313-1321.
108. Latcu D.G., Ricard P., Zarqane N., et al. Robotic magnetic navigation for ablation of human arrhythmias: initial experience. Arch Cardiovasc Dis 2009, 102:419-425.
109. Wu J., Pflaumer A., Deisenhofer I., et al. Mapping of atrial tachycardia by remote magnetic navigation in postoperative patients with congenital heart disease. J Cardiovasc Electrophysiol 2010, 21:751-759.
110. Kolandaivelu A., Lardo A.C., Halperin H.R. Cardiovascular magnetic resonance guided electrophysiology studies. J Cardiovasc Magn Reson 2009, 11:21.
111. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006-2014.
112. Nazarian S., Bluemke D.A., Halperin H.R. Applications of cardiac magnetic resonance in electrophysiology. Circ Arrhythm Electrophysiol 2009, 2:63-71.
113. Lardo A.C., McVeigh E.R., Jumrussirikul P., et al. Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging. Circulation 2000, 102:698-705.
114. Nazarian S., Kolandaivelu A., Zviman M.M., et al. Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation 2008, 118:223-229.